PRA International Agrees to Genstar Capital Buyout
In a move that will take Reston, Va.-based contract research organization (CRO) PRA International off the public market, the company has entered into an agreement to be purchased by Genstar Capital, a private equity group based in San Francisco. The deal is valued at $790 million.
PharmaNet Builds on Phase I Business with Toronto Facility
Princeton, N.J.-based contract research organization (CRO) PharmaNet Development Group is rejuvenating its early stage operations with the construction of a 160-bed, 40,000-square-foot, facility in Toronto, Canada.
Other Breaking News:
China and India join WHO clinical trials registry...
Target Health Memphis inks deal with arGentis Pharmaceuticals...
Company Profile: An interview with Matt Baker, president and chief executive officer, Compass IRB
To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.
